Skip to main content
Among the strongestOutperformers#11 of 115 by 1M spread

Healthcare Stocks

Top 10 of 60 XLV holdings, updated

As of 12 October 2026, healthcare stocks are among the strongest groups in the market, well ahead of the S&P 500. XLV beats the S&P 500 by 2.3 points over one month and ranks #11 of 115 groups Zensei tracks. 25 of the 60 healthcare stocks Zensei prices in XLV beat the fund this month.

Prices as of Last update : Beating the market → among the strongest
Beat the fund (1M)
25 of 60
Beat the S&P 500 (1M)
35 of 60
Strongest (1M)
MRNA +48.5%
Weakest (1M)
BMY −8.6%

Where healthcare stocks stand now

As of 12 October 2026, Healthcare (XLV) ranks #11 of the 115 groups Zensei tracks by one-month return against the S&P 500, inside the top tier of the market. It sits in the Outperformers quadrant of the rotation map: it has clearly beaten the S&P 500 by 2.3 points over the past month, on top of a 0.4-point advantage over the longer, time-shifted window.

On the shorter tape, XLV's momentum is weakening: the intraday trend that carried the move is cooling across the shorter windows. XLV's relative-strength line has broken below its long-term average — the long-term outperformance trend is no longer intact. Both signals point the same direction here: the market is not rewarding this group on either horizon.

The exposure comes via Health Care Select Sector SPDR, whose 60 tracked holdings are led by Eli Lilly, Johnson & Johnson and Abbvie Inc. Weighted by portfolio, the fund's holdings trade at roughly 30.8× earnings. The thing to watch from here is durability: outperformers that hold their one-month spread while the longer window keeps building tend to stay out front; a fading spread is the early exit signal.

1M spread vs SPY
+2.3 pts
Quadrant
Outperformers
Momentum
Weakening
RS health
Broken

As of , these are the largest healthcare stocks in XLV by fund weight, and the strongest over the past month. Size and recent return are measurements, not recommendations.

Top healthcare stocks by fund weight

Ranked by largest share of XLV

  1. 1Eli LillyLLY15.5%
  2. 2Johnson & JohnsonJNJ10.1%
  3. 3Abbvie IncABBV7.8%
  4. 4Merck & Co IncMRK5.7%
  5. 5UnitedHealth GroupUNH5.5%

Best healthcare stocks this month

Ranked by one-month return, among the holdings Zensei prices

  1. 1Moderna IncMRNA+48.5%
  2. 2Illumina IncILMN+34.0%
  3. 3Revvity IncRVTY+25.2%
  4. 4Mettler-Toledo International IncMTD+20.9%
  5. 5Agilent Technologies IncA+16.8%

Healthcare Stocks vs the S&P 500

Over the week to 12 October 2026, XLV rose 2.8% while the S&P 500 rose 0.4%. The table compares XLV and SPY (the S&P 500) over every window Zensei tracks. The spread is the difference: positive means XLV won that window.

Window
XLV
SPY
Spread
1 week+2.8%+0.4%+2.3 pts
2 weeks+0.7%+0.9%−0.1 pts
1 month+4.4%+2.1%+2.3 pts
3 months+7.0%+4.1%+2.8 pts
6 months+16.5%+12.6%+3.9 pts
1 year+23.0%+20.4%+2.6 pts

Prices as of · computed from daily adjusted closes · how we measure

Healthcare on the rotation map, against the 11 broad S&P 500 sectors. Vertical: 1-month spread vs the S&P 500. Horizontal: the longer, time-shifted window.

Are healthcare stocks expensive?

Fund P/E
30.8×
Weight with a P/E
94%

The price-to-earnings ratio of XLV as a whole: the total price of its holdings over their total earnings, weighted by share of the fund. Holdings that lose money are left out. Compare with every sector and theme: P/E ratio by sector.

XLV holdings: the healthcare stocks inside

This list covers all 60 healthcare stocks in XLV, heaviest first; the 10 largest show their returns where Zensei has a price. As of 12 October 2026, 25 of the 60 healthcare stocks Zensei prices in XLV beat the fund over the past month. 35 of them beat the S&P 500. The strongest is Moderna Inc (MRNA); the weakest is Bristol-Myers Squibb Co (BMY). Inside the fund, one or two outliers drive most of the move.

#HoldingWeight1M3Mvs fund 1MMomentumRS health
1
LLYEli Lilly
15.5%+5.9%+0.2%+1.5 ptsWeakStrong
2
JNJJohnson & Johnson
10.1%−0.6%+2.9%−5.0 ptsWeakBroken
3
ABBVAbbvie Inc
7.8%+9.3%+14.1%+4.9 ptsAcceleratingStrong
4
MRKMerck & Co Inc
5.7%+1.7%+18.0%
5
UNHUnitedHealth Group
5.5%+0.3%−11.4%
6
TMOThermo Fisher Scientific Inc
4.0%+8.7%+25.4%
7
AMGNAmgen Inc
3.6%+10.7%+16.5%
8
GILDGilead Sciences Inc
3.0%+5.3%+15.1%
9
ABTAbbott Laboratories
2.8%−0.1%+11.3%
10
PFEPfizer
2.6%+2.5%+18.1%
See all 60 holdings, each compared with the fund, with momentum and relative strengthSee the full breakdown

All 60 XLV holdings by weight: Eli Lilly (LLY) 15.5%, Johnson & Johnson (JNJ) 10.1%, Abbvie Inc (ABBV) 7.8%, Merck & Co Inc (MRK) 5.7%, UnitedHealth Group (UNH) 5.5%, Thermo Fisher Scientific Inc (TMO) 4.0%, Amgen Inc (AMGN) 3.6%, Gilead Sciences Inc (GILD) 3.0%, Abbott Laboratories (ABT) 2.8%, Pfizer (PFE) 2.6%, Intuitive Surgical Inc (ISRG) 2.4%, Danaher Corp (DHR) 2.2%, Vertex Pharmaceuticals Inc (VRTX) 2.1%, Bristol-Myers Squibb Co (BMY) 2.0%, CVS Health Corp (CVS) 1.8%, Medtronic PLC (MDT) 1.8%, McKesson Corp (MCK) 1.7%, Stryker Corp (SYK) 1.6%, Elevance Health Inc (ELV) 1.4%, The Cigna Group (CI) 1.2%, Moderna Inc (MRNA) 1.2%, Regeneron Pharmaceuticals Inc (REGN) 1.2%, HCA Healthcare Inc (HCA) 1.1%, Boston Scientific Corp (BSX) 1.0%, Cencora Inc (COR) 1.0%, Cardinal Health Inc (CAH) 0.9%, Becton Dickinson & Co (BDX) 0.8%, Edwards Lifesciences Corp (EW) 0.8%, Agilent Technologies Inc (A) 0.8%, Humana Inc (HUM) 0.8%, Waters Corp (WAT) 0.7%, Iqvia Holdings Inc (IQV) 0.7%, Veeva Systems Inc (VEEV) 0.7%, Illumina Inc (ILMN) 0.7%, Idexx Laboratories Inc (IDXX) 0.7%, Resmed Inc (RMD) 0.5%, Biogen Inc (BIIB) 0.5%, Centene Corp (CNC) 0.5%, Dexcom Inc (DXCM) 0.5%, Mettler-Toledo International Inc (MTD) 0.5%, Zoetis Inc (ZTS) 0.5%, GEHC 0.5%, West Pharmaceutical Services Inc (WST) 0.4%, Quest Diagnostics Inc (DGX) 0.4%, Labcorp Holdings Inc (LH) 0.4%, Viatris Inc (VTRS) 0.3%, Steris PLC (STE) 0.3%, Incyte Corp (INCY) 0.3%, Revvity Inc (RVTY) 0.3%, Zimmer Biomet Holdings Inc (ZBH) 0.3%, CRL 0.2%, Solventum Corp (SOLV) 0.2%, Baxter International Inc (BAX) 0.2%, Bio-Techne Corp (TECH) 0.2%, The Cooper Companies Inc (COO) 0.2%, Universal Health Services Inc (UHS) 0.1%, Insulet Corp (PODD) 0.1%, Align Technology Inc (ALGN) 0.1%, Henry Schein Inc (HSIC) 0.1%, Davita Inc (DVA) 0.1%.

Healthcare Stocks: common questions

Healthcare stocks list: which stocks are in XLV?

As of 12 October 2026, XLV holds 60 healthcare stocks, and this page lists all 60. The three largest by fund weight are Eli Lilly (LLY, 15.5%), Johnson & Johnson (JNJ, 10.1%) and Abbvie Inc (ABBV, 7.8%). Each one shows its fund weight; the 10 largest also show their one-month and three-month returns where Zensei has a price.

What are the best healthcare stocks this month?

As of 12 October 2026, ranked by one-month return, the three strongest healthcare stocks in XLV are Moderna Inc (MRNA, +48.5%), Illumina Inc (ILMN, +34.0%) and Revvity Inc (RVTY, +25.2%). This ranks past return only; it does not forecast the next month.

What are the top 3 healthcare stocks?

As of 12 October 2026, the three largest healthcare stocks in XLV by fund weight are Eli Lilly (LLY, 15.5%), Johnson & Johnson (JNJ, 10.1%) and Abbvie Inc (ABBV, 7.8%). Fund weight shows size inside the fund, not a recommendation.

Which healthcare stocks are beating the sector?

As of 12 October 2026, 25 of the 60 healthcare stocks Zensei prices in XLV beat the fund over the past month. The strongest over the past month is Moderna Inc (MRNA). The table above shows the largest holdings with their weights and returns.

Which ETF holds healthcare stocks?

Several ETFs hold healthcare stocks. Zensei tracks the group through XLV, the Health Care Select Sector SPDR. As of 12 October 2026, its published holdings list 60 healthcare stocks, and the 10 largest make up 60.6% of the fund.

Are healthcare stocks outperforming the S&P 500?

Yes. As of 12 October 2026, XLV has beaten the S&P 500 by 2.3 points over the past month.

What is XLV?

XLV is Health Care Select Sector SPDR. Zensei uses it to measure healthcare stocks against the S&P 500 (SPY).

What stocks does XLV own?

As of 12 October 2026, the largest of the 60 positions Zensei tracks in XLV are Eli Lilly, Johnson & Johnson, Abbvie Inc, Merck & Co Inc, UnitedHealth Group. Each position measured against the fund, with momentum and relative strength, comes with a free Zensei account.

What quadrant is healthcare in right now?

As of 12 October 2026, healthcare is in the Outperformers quadrant — outperforming the S&P 500 on both the recent and the longer, time-shifted window. The Zensei methodology page explains the quadrants.

Recent changes

  1. ·Beating the market → among the strongest
  2. ·Losing ground → beating the market
  3. ·First tracked: losing ground

Related sectors

Track healthcare against the whole market

Zensei Edge maps 100+ sectors and themes against the S&P 500 — with the stocks inside each one, rotation history and alerts when leadership changes hands.

Compare all sectors: Sector heat map · Sector P/E ratios